Twist Bioscience Corporation (TWST) - News Archive

In an era characterized by rapid advancements in genomic technologies, the collaboration between Twist Bioscience Corporation and Element Biosciences signifies a pivotal step toward optimizing next-generation sequencing...

Twist Bioscience: Leading the Charge in Biotechnological Innovation at the Upcoming J.P. Morgan Healthcare Conference South San Francisco, CA As the landscape of the life sciences sector continues to evolve, Twist Biosc...

Embracing Sustainability in Biotechnology: Twist Bioscience s Commitment to Corporate ResponsibilityIn a landscape increasingly dominated by environmental concerns and the quest for sustainability, Twist Bioscience Corp...

Twist Bioscience Corporation, a leading provider of high-quality synthetic DNA using its innovative silicon platform, has recently expanded its high-throughput antibody portfolio. The company announced the launch of a C...

Advances in Synthetic Biology: Twist Bioscience s New Launches in Viral Controls and High-Throughput ScreeningTwist Bioscience Corporation (NASDAQ: TWST), a company renowned for its innovations in synthetic DNA using it...

Twist Bioscience Joins AI Safety Consortium: A Leap Towards Trustworthy Biosecurity In an era where artificial intelligence (AI) and biotechnology are rapidly converging, ensuring the safety and trustworthiness of these...

Twist Bioscience Revolutionizes High-throughput Screening with the Launch of Multiplexed Gene FragmentsIn the field of pharmaceutical sciences, high-throughput screening (HTS) plays a crucial role in accelerating drug d...

Twist Bioscience Advancing Genetic Research with Innovative TechnologiesIn a recent announcement, Twist Bioscience Corporation revealed the launch of its Human Pangenome Spike-in for the Twist Exome 2.0 panel. This grou...

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome SequencingSOUTH SAN FRANCISCO, Calif. - Twist Bioscience Corporation (NASDAQ: TWST), a leading company in synthetic DNA production using its...

In a recent press release, Twist Bioscience Corporation (NASDAQ: TWST), a leading provider of high-quality synthetic DNA using its innovative silicon platform, announced that it has granted a total of 122,400 restricted...

In a groundbreaking collaboration, Twist Bioscience Corporation and Element Biosciences have joined forces to revolutionize exome sequencing and empower scientific advancements. Twist Bioscience, renowned for its state-...

Twist Bioscience Corporation (NASDAQ: TWST), an industry trailblazer renowned for their success in offering high-quality synthetic DNA via a silicon platform, has officially announced early access to their groundbreakin...

Twist Bioscience Corporation, the renowned provider of high-quality synthetic DNA solutions using its state-of-the-art silicon platform, has announced the expansion of its revolutionary gene synthesis service, Twist Exp...

SOUTH SAN FRANCISCO, Calif. - Twist Bioscience Corporation (NASDAQ: TWST) has recently made an announcement regarding inducement grants under NASDAQ Listing Rule 5635(c)(4). As per the requirements of the Nasdaq Stock M...

Twist Bioscience Welcomes Adam Laponis as New CFO, Boosting Financial Expertise and Strategic Planning for Future GrowthSOUTH SAN FRANCISCO, Calif. - Twist Bioscience Corporation (NASDAQ: TWST) has recently announced th...

Twist Bioscience Revolutionizes Gene Synthesis with the Launch of Twist Express Genes: Quick Turnaround and High-Quality DNA DeliverySOUTH SAN FRANCISCO, Calif. - In a groundbreaking move that will transform the field o...

Twist Bioscience Corporation (NASDAQ: TWST), a leading synthetic DNA provider, recently announced the issuance of inducement grants to newly hired individuals as a means to attract and retain top talent. This move refle...

In an era where advancements in genetic research are transforming healthcare and enabling groundbreaking innovations, Twist Bioscience Corporation has emerged as a frontrunner. The California-based company has once agai...